Cytomegalovirus retinitis in AIDS: natural history, diagnosis, and treatment.

Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Cytomegalovirus retinitis in AIDS: natural history, diagnosis, and treatment.

AIDS Clin Rev. 1995-96;:99-129. Unique Identifier : AIDSLINE MED/96089199
Dunn JP; Jabs DA; Johns Hopkins University School of Medicine, Baltimore, Maryland,; USA.

Abstract: Cytomegalovirus retinitis is the most common intraocular infection and the leading cause of blindness in patients with AIDS. Diagnosis is made on clinical grounds; a variety of other infectious and neoplastic retinitides should be considered in the differential diagnosis. Treatment with intravenous ganciclovir or foscarnet has been proven effective, but late complications of relapse, viral resistance, retinal detachment, and drug toxicity remain problematic. Approved and investigational drugs for the treatment of CMV retinitis are limited by their virostatic, rather than virocidal, properties. Because the efficacies of ganciclovir and foscarnet are similar, the choice of therapy should be based on systemic considerations such as drug toxicity and patient survival. The cost, toxicity, and limited efficacy of currently available therapy of CMV retinitis make the need for an effective prophylactic drug even more important.

Keywords: AIDS-Related Opportunistic Infections/DIAGNOSIS/*DRUG THERAPY Cytomegalovirus Infections/DIAGNOSIS/*DRUG THERAPY Human Retinal Detachment/ETIOLOGY Retinitis/COMPLICATIONS/DIAGNOSIS/*DRUG THERAPY JOURNAL ARTICLE REVIEW REVIEW, ACADEMIC
960330
M9630749

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .